Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Epilepsy study sheds light on survival chances
Italian spinone
Researchers found affected dogs with no cluster seizures lived significantly longer.
Research uncovers prevalence of IE in Italian Spinoni

Idiopathic epilepsy is more prevalent in Italian Spinoni that the general canine population, according to research by the Animal Health Trust (AHT). Their study, believed to be the first of its kind, may help to improve survival in these dogs.

Over 5 per cent of the Italian Spinoni involved in the research were found to have the condition. In the UK's general canine population, prevalence is estimated to be just 0.6 per cent, though it can be as high as 18.3 per cent, depending on country and breed.

In the AHT's survey of 1,192 Spinone owners, 63 dogs had idiopathic epilepsy (IE). The owners of these dogs were then invited to complete a further questionnaire and make available their dog's medical records.

Looking at the survival times of the affected dogs, researchers found those with no cluster seizures lived significantly longer. Survival was also substantially longer in Italian Spinoni whose treatment with anti-epileptic medication had started after the second seizure, rather than after the third.

Lead author Luisa De Risio explained: "From this sample we were able to conclude that idiopathic epilepsy in this breed often has a severe presentation but starting treatment with antiepileptic medication after the second seizure, and aggressive treatment of cluster seizures, may improve the survival of these dogs."

IE is the most common, chronic neurological disorder seen in dogs, but appears more commonly in some breeds than others, including Irish wolfhounds, border collies and of course, Italian Spinoni. It is a very complex and difficult disease to treat in dogs, just as it is in humans.

Work is also underway at AHT to identify the genetic mutations responsible for the disease so a genetic test could be developed. Due to the complexity of the genetics, however, such a test is most likely "many years away", Dr De Risio says.

In the meantime, she adds: "We hope these findings will help to increase veterinary knowledge and understanding of this horrible disease and give Italian Spinoni, and other affected breeds, the best chance of fighting IE."

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.